ITEMS OF INTEREST TO THE IMAGING RESEARCH COMMUNITY:
- NEW WEB ADDRESS FOR OER WEB SITES - FOLLOW-UP(NOTICE: OD-00-020)
As announced in the August 13, 1999 NIH Guide for Grants and Contracts, the Web address for the OER Grants and Training Opportunities Web sites has changed as follows:
Previous Web Address for Grants main page: http://grants.nih.gov/grants/oer.htm
New Web Address for Grants main page: http://grants.nih.gov/grants/oer.htm
Previous Web Address for Training main page: http://www.nih.gov/training/
New Web Address for Training main page: http://grants.nih.gov/training
All Web pages within these sites have had a similar address change. As a general rule, substituting "grants." for "www." will allow for maintaining links from previous bookmarks. This announcement is to notify the community that ALL PAGES FROM THE PREVIOUS SITE WILL BE DELETED AS OF MARCH 1, 2000. Re-director pages from the previous site will continue to be in place for top-level and secondary pages for at least another 6 months. This web address change includes the NIH Guide for Grants and Contracts' address.
- CHANGE OF RECEIPT DATE FOR INTERDISCIPLINARY RESEARCH TEAMS FOR MOLECULAR TARGET ASSESSMENT (NOT-CA-00-009) (NCI)
The National Cancer Institute (NCI) wishes to give notice of a change of receipt date for applications submitted in response to RFA CA-00-001, Interdisciplinary Research Teams For Molecular Target Assessment. This RFA can be accessed at the following URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-00-001.html
The previous receipt date of March 15, 2000 has been changed to June 20, 2000.
- APPLICATION FOR CONTINUATION OF A PUBLIC HEALTH SERVICE GRANT (PHS 2590) FACE PAGES (NOTICE: OD-00-021) (NIH)
NIH has experienced an unanticipated depleted supply of the form used to produce the computer-generated Application for Continuation of a Public Health Service Grant (PHS 2590) face page. As a result, there has been a delay in mailing the pre-printed 2590 face pages and mailing labels. Grantees with noncompeting applications due to NIH in March for award budget periods beginning in May are strongly encouraged to complete a blank 2590 face page to submit with your applications. Blank 2590 face pages (Form Page A) are available in PDF format from the NIH website at http://grants.nih.gov/grants/funding/2590/2590.htm
- MOLECULAR TARGET DRUG DISCOVERY FOR CANCER (RFA-CA-00-002) (NCI)
Letter of Intent Receipt Date: June 6, 2000; Application Receipt Date: July 18, 200
The Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, NCI, and the Chemoprevention Agent Development Research Group, the Division of Cancer Prevention, NCI, invite cooperative agreement applications to exploit molecular targets for drug discovery. New insights into our understanding of cancer cell biology provide a new opportunity for a fundamental re-ordering of approaches to cancer drug discovery. Rather than depending on in vitro and in vivo screens for antiproliferative activity, investigators can now focus on new molecular targets and pathways essential for the development and maintenance of the cancer phenotype.
- MOLECULAR TARGET DRUG DISCOVERY FOR CANCER: EXPLORATORY GRANTS (PAR-00-060) (NCI)
Letter of Intent Receipt Date: June 6, 2000; Application Receipt Date: July 18, 2000
For the program described just above in item 4., NCI invite exploratory/developmental grant applications (R21) to exploit molecular targets for drug discovery.
- MOLECULAR TARGET DRUG DISCOVERY FOR CANCER: SMALL BUSINESS GRANTS (PAR-00-061) (NCI)
Letter of Intent Receipt Date: June 6, 2000; Application Receipt Date: July 18, 2000
For the program described just above in item 4., NCI invite Small Business Innovative Research Program (SBIR) and Small Business Technology Transfer Program (STTR) applications to exploit molecular targets for drug discovery.
- ACTIVITIES TO PROMOTE RESEARCH COLLABORATIONS (CA-00-007) (NCI)
To support and encourage scientific collaboration among National Cancer Institute (NCI) grantees as well as with other members of the scientific community, the Division of Cancer Biology (DCB) of the NCI announces the availability of two administrative mechanisms to facilitate such interactions under a program entitled Activities to Promote Research Collaborations (APRC). A full description of this program can be accessed at the following website: http://www.cancer.gov/dcb/colabbrf.htm#resclab
It details the opportunities available to DCB grantees for collaborative activities through administrative supplements to their active grants and the mechanisms for requesting such supplements.
- SKELETAL MUSCLE PERFUSION, AGING AND CARDIOVASCULAR DISEASE (PA-00-056)(NIA, NIAMS, NIDDK)
The National Institute on Aging (NIA), the National Institute of Arthritis and Musculoskeletal and Skin Diseases(NIAMS), and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invite exploratory research grant applications (R21) for studies of whether aging and/or chronic diseases common to old age, may negatively impact on skeletal muscle perfusion and thereby lead to potential metabolic disorders or limit physical performance in older persons.
- CANCER EDUCATION AND CAREER DEVELOPMENT PROGRAM (PAR-00-064) (NCI)
The purpose of this specialized Cancer Education Program (R25) is to support the development and implementation of curriculum-dependent programs to train predoctoral and postdoctoral candidates in cancer research settings that are highly inter-disciplinary and collaborative.
- THE HOWARD TEMIN AWARD (PAR-00-066) (NCI)
The goal of the National Cancer Institute's (NCI) Howard Temin Award is to bridge the transition from a mentored research environment to an independent research career for scientists who have demonstrated unusually high potential during their initial stages of training and development. The major objective of the award is to sustain and advance the early research careers of the most promising M.D.s and Ph.D.s while they consolidate and focus their independent research programs, and obtain their own research grant support.
- ACADEMIC CAREER AWARD (K07) (PA-00-070) (NIA, NIAA, NCI, NIMH, NCCAM)
The Academic Career Award (K07) is used by the NIH Institutes and Centers to support individuals interested in introducing or improving curricula in a particular scientific field as a means of enhancing the educational or research capacity at the grantee institution.
OTHER GOVERNMENT AGENCIES
- DEPARTMENT OF DEFENSE PROSTATE CANCER RESEARCH PROGRAM FOR 2000 (SOL CBD-PCR-0223)
Application receipt date: May 17, 2000
The Fiscal Year (FY) 2000 Defense Appropriations Act provides $75M to the Department of Defense (DOD) Prostate Cancer Research Program (PCRP). The programmatic strategy for the FY00 PCRP is to fund proposals in two research award categories (Idea Development Awards and New Investigator Awards) and in three training award categories (Postdoctoral Awards, Minority Population Focused Collaborative Training [MPFCT] Awards, and Historically Black Colleges and Universities/Minority Institutions [HBCU/MI] Academic Development Awards). POC Craig D. Lebo, Contracting Officer, 301-619-2036
URL : http://cdmrp.army.mil
- DoD Breast Cancer Research Program
Receipt deadline: April 12, 2000. Research dollars will be available no later than Sept 30, 2000.
Approximately $3.5M of the BCRP's FY99 appropriation has been set aside for Concept Awards. The intent of Concept Awards is to fund an initial concept or theory that could give rise to a testable hypothesis. Concept Awards can be requested for $50,000 for direct costs over a 1-year performance period, plus indirect costs as appropriate. To obtain a copy of the Concept Award Program Announcement and electronic Concept Proposal Submission Form, visit the CDMRP web site at http://cdmrp.army.mil/?/announce
Additional information about the BCRP and other CDMRP-sponsored programs and events can also be found on the web site at http://cdmrp.army.mil
- NSF Biophotonics Partnership Initiative (NSF 00-54)
DEADLINE DATE: MAY 15, 2000, 5:00 PM (your local time)
The Engineering Directorate of the National Science Foundation (NSF) announces a Biophotonics Partnership initiative seeking high risk/high return, multidisciplinary studies of novel concepts in biophotonics. Incremental advances of existing technologies will not be considered. NIH and DARPA will participate in the reviews.
- UNIVERSITY OPTOELECTRONICS CENTERS (SOL RA00-26)
The Defense Advanced Research Projects Agency (DARPA) is soliciting proposals to establish University Optoelectronics Centers for research focused on the application of optoelectronic and photonic technologies in future generations of sensing, information access, and information processing systems. Proposals from teams of academic researchers to establish optoelectronics centers are solicited. POC Dr. David Honey and Dr. Elias Towe, DARPA/MTO, FAX: (703) 696-2206.
URL: http://www.darpa.mil ; E-MAIL: RA00firstname.lastname@example.org
- WHITAKER FOUNDATION SPECIAL OPPORTUNITY AWARDS
Special Opportunity Awards support the development of quality programs that substantially enhance the field of biomedical engineering. The emphasis is on education, rather than on solving specific research problems. Applications will be accepted from universities, professional organizations, and nonprofit and non-governmental institutions in the United States and Canada. The maximum award is $1 million over three years, and it is not renewable. An institution may submit up to two applications, but the applications should not overlap and they must have different program directors.
The Diagnostic Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.
If you wish to remain on the list, no action is necessary.
If you wish to be added to the list (or removed from it), please contact Johnnie Smith by return e-mail (email@example.com).
The staff of the Diagnostic Imaging Program places a high priority on communicating with and facilitating the work of researchers in the imaging community. We look forward to working with you.
Diagnostic Imaging Program Division of Cancer Treatment and Diagnosis, NCI Executive Plaza North, Room 800 6130 Executive Boulevard Rockville, MD 20892-7440 Tel: 301 496 9531 Fax: 301 480 5785